Expression of beta-amyloid precursor protein mRNAs following transient focal ischaemia

Neuroreport
J KoistinahoT Hökfelt

Abstract

beta-Amyloid precursor protein (beta APP) can be alternatively processed to result in release of either neurotoxic amyloid beta-peptide, or secreted forms of beta APP, which might have a role in neuronal plasticity and survival. Four different forms of beta APP mRNAs have been described in rodents: APP695, APP714, APP751 and APP770. The two larger forms contain a Kunitz-type serine protease inhibitor domain (KPI). Since previous studies have shown increased APP immunoreactivity following brain ischaemia, we used in situ hybridization histochemistry to determine whether induction of any APP mRNA transcripts take place following focal brain ischaemia. While the hybridization signal of all APP isoforms in the infarct was lost 4-24 h following the insult, APP770 mRNA was slightly upregulated in the ipsilateral cortex and striatum 3 days after 90 min ischaemia. At 7 days post-ischaemia APP770 and APP751 mRNAs were induced in the infarct core and in a thin perifocal zone. KPI-containing APP forms are differentially induced following focal brain ischaemia, possibly as a neuroprotective response to neuronal injury.

Citations

Dec 13, 2002·The Journal of Biological Chemistry·Ian F SmithChris Peers
May 20, 2003·Journal of Neurochemistry·I F SmithC Peers
Nov 18, 2003·Arteriosclerosis, Thrombosis, and Vascular Biology·Costantino Iadecola
Jun 17, 2005·Journal of Neural Transmission·J SzczygielskiO Wirths
Oct 7, 2016·Pharmacological Reports : PR·Marzena Ułamek-KoziołStanisław J Czuczwar
Oct 22, 2002·Journal of Neuropathology and Experimental Neurology·Kathy Keyvani, Timothy Schallert
Nov 19, 2019·Translational Neuroscience·Pelin Kelicen-UgurHande Karahan
Aug 1, 1997·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·J P MacManus, M D Linnik
May 2, 2001·Journal of Neurochemistry·K N Green, C Peers
Dec 24, 2003·Teratogenesis, Carcinogenesis, and Mutagenesis·Eduardo CemeliDiana Anderson
Dec 3, 2005·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Chris PeersHugh A Pearson
Jul 19, 2012·Journal of Cellular and Molecular Medicine·Timo SarajärviMikko Hiltunen
Feb 13, 2013·Neurotoxicity Research·Mak Adam Daulatzai
Mar 5, 2016·Pharmacological Reports : PR·Marzena Ułamek-KoziołStanisław J Czuczwar
Dec 18, 2002·Journal of Neuropathology and Experimental Neurology·Akira IwataDouglas H Smith
Dec 11, 2002·Journal of Neurochemistry·Nicola J WebsterPeter F T Vaughan
Nov 21, 2013·Acta Neuropathologica Communications·Dimitrije Krstic, Irene Knuesel
Oct 21, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Jason L ScraggChris Peers
May 6, 2020·International Journal of Molecular Sciences·Ryszard PlutaStanisław J Czuczwar
Nov 28, 2009·The Anatomical Record : Advances in Integrative Anatomy and Evolutionary Biology·Ryszard PlutaMirosław Jabłoński
Jul 23, 2011·Physiological Research·M JabłońskiR Pluta
Apr 21, 1999·Brain Research. Brain Research Reviews·M WaltonM Dragunow
Jul 12, 2005·Biochemical and Biophysical Research Communications·Kentaro Oh-hashiKazutoshi Kiuchi
Jun 8, 2007·Neuron·Giuseppina TescoRudolph E Tanzi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Brain Ischemia

Brain ischemia is a condition in which there is insufficient blood flow to the brain to meet metabolic demand. Discover the latest research on brain ischemia here.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.